← Open Payments lookup

MAHENDRA PATIL: Open Payments

NPI 1558424945 · KITTANNING, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$909 in 47 payments from 10 companies in 2025. Trend: 2023 $1,137 · 2024 $1,270 · 2025 $909

Food & beverage: $909
CompanyPaymentsAmount
Neurocrine BioSciences, Inc.9$174
Otsuka America Pharmaceutical, Inc.9$158
Alkermes, Inc.8$156
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)5$120
Teva Pharmaceuticals USA, Inc.5$107
ABBVIE INC.3$62
Lundbeck LLC3$56
E.R. Squibb & Sons, L.L.C.2$31
Supernus Pharmaceuticals, Inc.2$29
Takeda Pharmaceuticals U.S.A., Inc.1$15

Products named: REXULTI, INGREZZA, CAPLYTA, UZEDY, LYBALVI, VRAYLAR, ARISTADA, COBENFY.

Industry payments across PA — which companies pay providers there.